Tomsick and Abbottsmith Receive Kaplan Award
Thomas Tomsick, MD, and Charles Abbottsmith, MD, have won the Samuel Kaplan, MD, Visionary Award for their contributions to cardiovascular medicine.
Dr. Tomsick, professor and director of neuroradiology, and Dr. Abbottsmith, adjunct professor of cardiology, received their awards Feb. 26 at the American Heart Associations 11th Annual Heart Ball.
Dr. Tomsick has been a member of the College of Medicine faculty since 1976 and is a world-renowned interventional neuroradiologist. He pioneered new treatments for bleeding strokes and also helped develop techniques that deliver clot-busting drugs directly to the blockage in the brain.
Dr. Abbottsmith, director of cardiology at The Christ Hospital, received the award for his innovations in cardiovascular research over three decades.
The award honors those who continue the tradition of excellence in cardiovascular science exemplified by Dr. Kaplan, founder and former director of cardiology at Cincinnati Childrens and former professor of pediatric cardiology at UC.
With Leland Clark, PhD, Dr. Kaplan pioneered the use of the heart-lung machine, and also led the development of cardiac catheterization and echocardiology. He is now on the faculty of the University of CaliforniaLos Angeles.
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.